113 results

Oil prices slid on uncertainty over whether US president Donald Trump would withdraw from the Iran nuclear deal

European shares edged up 0.1 per cent on Tuesday, but Italian stocks were a weak spot as the threat of a snap election grew, while earnings and deal-m(...)

Paper and packaging group Smurfit Kappa fell more than 3 per cent to €34.38.

Worries over rising bond yields and falling metals prices trumped well-received earnings updates from Kering and Credit Suisse on Wednesday, sending E(...)

Shares in Takeda tumbled further on Wednesday on news of the Shire deal. Photograph: Suzanne Plunkett/Reuters

Rare disease drug maker Shire said on Tuesday it was willing to recommend a sweetened $64 billion offer from Japan’s Takeda to shareholders, in what (...)

Shire’s board “is considering its position” on a new bid from Takeda.

Dublin-based pharma giant Shire is considering a new offer from Takeda Pharmaceutical after the Japanese drugmaker revised its roughly $60 billion (€4(...)

Allergan had about $30.1bn in debt and $6.45bn in cash at the end of the year

Japan’s Takeda Pharmaceutical increased its offer for Irish pharma group Shire to £47 (€53.65) a share on Friday after its three previous bids – the l(...)

Takeda said it offered had £46.50 (€53.46) a share in cash and stock last week for Shire in a bid to extend its global reach.

Shire shares surged following a report that Allergan is considering a bid for the drugmaker to compete with Takeda Pharmaceutical’s $60 billion (€48,(...)

Takeda is not considering purchasing only some businesses or assets, Credit Suisse said in a note. Photograph: Kim Kyung-Hoon/Reuters

Takeda Pharmaceutical chief executive Christophe Weber is contemplating a deal for all of Shire, telling a select audience that size is not an obstacl(...)

Traders work on the floor of the New York Stock Exchange as markets react to a trade dispute between China and the United States. Photograph: Justin Lane/EPA

European shares fell as China’s response to US tariffs fuelled fears of a trade war. DUBLIN The Irish market reflected the rest of Europe. Cider mak(...)

Is Takeda’s pursuit of Irish rare disease drug group Shire over even before it has properly begun? Photograph: Suzanne Plunkett/Reuters

Is Takeda’s pursuit of Irish rare disease drug group Shire over even before it has properly begun? Japan’s largest drugmaker was flushed out into the(...)

Shire said it had not received any formal approach or offer from Takeda Pharmaceutical. Photograph: Suzanne Plunkett/Reuters

Shares of Takeda Pharmaceutical fell the most in nine years after the company disclosed it was considering a bid for Irish pharmaceuticals group Shire(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
  • Last »